Gates Visits Beijing Kexing Biological Products Co., Ltd.

　　 Gates The visit lasted nearly 3 hours. The content was launched around the vaccine, involving the current status of vaccine production, development and application in China. It was rushed to Shenzhen on September 27th night to join Buffett, who is visiting the Byd Co.

Soon to be held with Chinese tycoons Charity dinner Bill Gates, the two world class richest man, will pay close attention to the trip to China with Warren Buffett. According to Caixin reporter, Gates arrived in Shenzhen on the night of September 27th and confluence with the local inspecting Byd Co of Buffett.

This information is revealed by Gates on his personal micro-blog. A recently updated micro-blog showed that at 20:00 on September 27th, Gates was on the way to Shenzhen to meet with Warren and others - to spend some time in BYD, and to understand innovation in batteries, energy and transportation.

In fact, according to Caixin reporter, the main topics of Gates's trip include vaccines, energy, transportation and charity.

Gates's schedule is quite compact. So far, it is known that he has visited the Beijing Office of the Bill and Melinda Gates Foundation (hereinafter referred to as the Gates Foundation), an important Chinese vaccine company and the Chinese Ministry of Microsoft research.

Among them, Gates visited the vaccine business is Beijing Kexing Biological Products Co., Ltd. The company's stakeholders have confirmed Gates's visit to Caixin correspondent. It is reported that Gates's visit to Kexin lasted nearly 3 hours, and the content was launched around the vaccine. Prior to this, He Yiwu, senior project manager of the Gates foundation, has revealed that the objective of Gates's inspection will involve the current status of vaccine production, development and application in China.

　　 Beijing Kexing Biological Products Co., Ltd. (SINOVAC BIOTECH CO., LTD.) is a biotechnology high tech enterprise jointly established by Kexing Holdings (Hongkong) Limited (Sinovac Biotech) (Hong Kong) Ltd. and Beijing Peking University unnamed bio engineering Refco Group Ltd. In 2001, the company was registered in Peking Biological Park, Zhongguancun high tech park, Beijing, and attracted much attention in the first six months after SARS in 2003, which developed the "SARS virus inactivated vaccine".

Vaccines have always been the focus of Gates's attention. At the beginning of 2010, the Gates Foundation launched by Gates announced that the global alliance for vaccines and immunization was 10th anniversary, and announced that it would provide us $10 billion over the next ten years to speed up the global vaccine promotion.

He Yiwu also said in public that the Gates Foundation hopes that Chinese enterprises will provide vaccines for developing countries. Its cooperation with Chinese vaccine enterprises will adopt a diversified and flexible way. Besides financial support, it can also give support to marketing channels and capacity expansion. The vaccines are mainly targeted at pneumonia, malaria, dysentery and smallpox; the reason why China is chosen is that the quality and production capacity of Chinese vaccines are very good and prices are relatively cheap.

What is interesting is that although the Gates foundation involved in planning Gates's trip is very confidential about its itinerary, Gates himself has revealed his personal whereabouts and purposes on micro-blog.

At 20:50 on September 24th at Beijing time, Gates released the first micro-blog trip to China related to micro-blog's "learning trip" - vaccine, energy, transportation and charity.

At 8:05 on September 25th, Gates wrote, "arrive at the office of our foundation in Beijing." At 14:30 in the afternoon, Gates's two micro-blog showed that he was visiting a "life saving vaccine" in Beijing Kexing company, and met with scientists in Beijing and Kexing company.

A recent update of micro-blog showed that at 11:45 on September 26th, Gates met with researchers from the Chinese Ministry of Microsoft Research Institute to see what they were studying and other projects.